Literature DB >> 11091203

Granulocyte colony-stimulating factor production by adult T-cell leukaemia cells.

K Matsushita1, N Arima, K Yamaguchi, T Matsumoto, H Ohtsubo, S Hidaka, H Fujiwara, K Arimura, T Kukita, Y Tokito, A Ozaki, C Tei.   

Abstract

We previously demonstrated that, in about 30% of primary adult T-cell leukaemia (ATL) cases, the leukaemic cells proliferated in response to granulocyte colony-stimulating factor (G-CSF). In the present report, we describe five patients with the acute leukaemia type of ATL who showed marked neutrophilia and elevated serum G-CSF concentrations in the absence of infection. We further examined two of these patients for detailed clinical features and cellular characteristics of the tumour cells. The white blood cell counts of both patients were 62 x 10(9)/l, consisting of approximately 90% neutrophils and 10% ATL cells. Serum concentrations of G-CSF in the two patients were 138 pg/ml and 93 pg/ml. The G-CSF concentrations in supernatants of short-term cultures of the patients' peripheral blood T-cells were 2 5 pg/ml and 13 pg/ml respectively. Immunostaining with anti-G-CSF antibody demonstrated G-CSF production by primary ATL cells in both cases. The neutrophil count fluctuated simultaneously with activity of ATL. Primary ATL cells from one patient were shown to proliferate in response to G-CSF in vitro. These results suggest autocrine growth stimulation of primary ATL cells in a subgroup of patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091203     DOI: 10.1046/j.1365-2141.2000.02257.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  A rapid increase in the normal white cell counts without blasts as the initial presentation of T-cell acute lymphoblastic leukaemia.

Authors:  Susumu Inoue; Jitendra Sah; Nkechi Onwuzurike
Journal:  BMJ Case Rep       Date:  2013-07-23

2.  Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients.

Authors:  Kenji Ishitsuka; Hiroo Katsuya; Tomona Toyota; Masanao Ishizu; Naoko Kunami; Mana Fujita; Hidenori Sasaki; Yasushi Takamatsu; Masanobu Uchiyama; Haruo Fujikane; Kentaro Ogata; Shuuji Hara; Kazuo Tamura
Journal:  Int J Hematol       Date:  2010-11-16       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.